Answers are grounded in this paper and cite their sources.
Three patients with premenstrual dysphoric disorder (PMDD) and recurrent vulvovaginal candidiasis (VVC) underwent sertraline therapy (Tresleen, a selective serotonin-reuptake inhibitor; Pfizer) for PMDD. During sertraline intervention, patients had no recurrent episodes of acute VVC. Antifungal activity was observed for sertraline against various isolates of Candida species.
No takes yet. Share an insight, caveat, or question.
Lass‐Flörl et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: